ERBB2 and neoplasm: All of these characteristics were in accordance with the known tumor biology and aggressiveness of HER2-positive metastatic gastric cancer in Chinese patients, with similar data observed in the ToGA [5], HELOISE [26], and EVIDENCE studies [27].